Uncategorized

Relative value in IO backed by seasoned legacy loans

admin | June 28, 2019

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

The steady drop in interest rates this year has started to spur prepayments of 50 CPR or higher in new prime and near-prime private MBS, sending some investors looking for more stable cash flows. There may be a surprising source: interest-only or IO bonds backed by seasoned legacy collateral. These IOs offer negative duration without significant negative convexity, and the likely carry is attractive. The IOs could work well for portfolios that hedge IO or use it to shorten duration in a broader portfolio.

Stable prepayments in legacy collateral

The appeal of IO backed by legacy collateral clearly is the collateral itself. Loans backing NRZT trusts, for example, come from exercising call options on legacy private label deals. The collateral is a combination of seasoned always-performing, self-cured and modified re-performing legacy loans. The combination of burnout and credit impairment help drive generally low and consistent prepayments despite high WACs with significant refinancing incentive. Lower mortgage rates have by and large not driven a material uptick in speeds across the program. (Exhibit 1)

Exhibit 1: NRZT 2016-1 3-month VPR versus Freddie Mac Primary Rate

Source: Bloomberg, Amherst Pierpont Securities

Although NRZ and other legacy loans may be newly re-securitized, tracing the loans back to their former lives in legacy trusts shows both pre- and post-issuance performance through a number of refinancing waves. NRZT 2018-1A, for example, has only 14 months of prepay history. The WALA on the collateral, however, is 140 months. The longer pre-securitization prepayment rate is calculated using weighted average historical prepayment rates on the always performing and re-performing loans in the called legacy deals collateralizing the NRZT trust (Exhibit 2).

Exhibit 2: NRZT 2018-1 – Pre and Post Securitization Prepayment Rates

Source: Amherst Insight Labs, Amherst Pierpont Securities

Nuances of IO structure

The combined effect of structure and collateral creates an instrument with both negative duration and limited negative convexity—or positive convexity based on some models— that could pair well with longer duration, negatively convex classes of newly issued private label RMBS. IO stripped off the ‘AAA’ classes of NRZT seasoned loan trusts are pass-through strips off a shifting interest structure, making them similar to front sequential IO. The subordinate classes are locked out from receiving unscheduled principal for five years if the deal passes performance triggers, paying the principal instead to the ‘AAA.’. In the case of NRZT 2018-1A, the ‘AAA’ class currently represents the top 71.4% of the structure. The A1IA is a WAC coupon IO currently struck at 1.87%. The coupon on the IO can drift higher or lower based on the coupon of loans that leave the pool either through prepayment or default and subsequent liquidation. And while the prepayment rates have proven to be stable, they are likely not completely impervious to a higher rates and a subsequent slowdown in speeds causing it extend and giving it negative duration. (Exhibit 3)

Exhibit 3: Collateral and Risk Profiles of NRZT and Seasoned FNMA IO

Source: Bloomberg, Amherst Pierpont Securities

Positively convex IO is extraordinarily rare. Given their levered prepayment risk, IOs generally exhibit significant amounts of negative convexity. Models view some IO off legacy collateral as positively convex, although these IO have not been tested across a wide set of markets. The opinion of traders on realized convexity varies from essentially zero to a small negative.

Relative value to agency IO

The NRZT ‘AAA’ IO compares favorably to a comparable agency IO. Comparing the NRZT IO to a seasoned higher coupon agency IO like FNR 2015-33 AI, a 5% IO backed by 5.49% WAC, 190 WALA Fannie Mae 5.0% collateral is a reasonable albeit imperfect comparison. The Fannie bond has a much lower WAC and is more seasoned than the NRZT bond. The bonds trade to roughly comparable IO multiples with the Fannie IO trading at roughly a 3.7 times coupon multiple. The Fannie Mae IO has significantly more negative duration given the fact it is a true pass-through strip and the cash flow can extend more into a back-up in rates. Pairing the Fannie Mae IO with TBA FNCL 3.0% leaves it duration-neutral to the NRZT IO. The NRZT IO still outperforms the combination of agency IO and TBA by a projected 44 bp in the base case. As rates shift, the NRZT IO significantly outperforms the combo by as much as 249 bp given the far more stable collateral. (Exhibit 4)

Exhibit 4: 12 Month Total Return – NRZT versus seasoned FNMA IO & TBA

Note: projected total returns assume parallel, linear shift in rates to the horizon, reinvestment at 1-month LIBOR and repricing at constant OAS. All market levels as of 6/27/19. Source: Yieldbook, Amherst Pierpont Securities

Given its negative duration, relative stability and attractive yield in a low rate environment, seasoned private MBS IO offers a clear relative value alterative to higher coupon seasoned IO.

admin
jkillian@apsec.com
john.killian@santander.us 1 (646) 776-7714

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.